Hemlibra Works to Reduce Bleeding Rates in Hemophilia A Children

Hemlibra Works to Reduce Bleeding Rates in Hemophilia A Children

307155

Hemlibra Works to Reduce Bleeding Rates in Hemophilia A Children

Preventive treatment with Hemlibra (emicizumab) safely and effectively reduced bleeding rates in children with hemophilia A who were treated at a center in Texas, according to a new report. “We demonstrate a successful experience with emicizumab prophylaxis and safe [surgical] approach with a focus on minimizing postoperative bleeding,” the researchers wrote. The study, “Emicizumab in pediatric hemophilia: Bleeding and surgical outcomes from a single-center retrospective study,” was published in the journal Pediatric Blood & Cancer.…

You must be logged in to read/download the full post.